Aberrantly High Expression Of NOK/STYK1 Is Tightly Associated With The Activation Of The AKT/GSK3β/N-Cadherin Pathway In Non-Small Cell Lung Cancer.

Onco Targets Ther · 2019 · PMC6885570 · PMID 31819514

Europe PMC DOI

hedged sentence

0.0790

closest p · 1.6× alpha

0.0790

boldest claim

The sentences

showed a trendP= 0.0790so close (0.05 < p ≤ 0.1)

The K-M survival analysis revealed that patients with high NOK expression (median survival time: 12.0 months) showed a trend of shorter OS than those of low NOK expression (median survival time: 19.5 months, P= 0.0790; Supplementary Figure 1 ), which was consistent with our previous study. 12 The association between NOK expression and the clinicopathological variables was analyzed ( Table 1 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.